MADRIGAL PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Madrigal Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Madrigal Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$163M, a 88% decline year-over-year.
  • Madrigal Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$530M, a 60.5% decline year-over-year.
  • Madrigal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$380M, a 29.6% decline from 2022.
  • Madrigal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$294M, a 21.1% decline from 2021.
  • Madrigal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$242M, a 17.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$530M -$163M -$76.1M -88% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$454M -$152M -$73.7M -94.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$380M -$117M -$31.9M -37.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$349M -$98.5M -$18.1M -22.5% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-28
Q2 2023 -$330M -$86.5M -$16.2M -23% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$314M -$78.3M -$20.7M -36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$294M -$85.3M -$20.7M -32% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$273M -$80.4M -$17.3M -27.3% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-28
Q2 2022 -$256M -$70.3M -$8.53M -13.8% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-28
Q1 2022 -$247M -$57.6M -$4.61M -8.7% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-28
Q4 2021 -$242M -$64.6M -$5.05M -8.47% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-03
Q3 2021 -$237M -$63.2M -$4.37M -7.44% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-03-03
Q2 2021 -$233M -$61.7M -$11.4M -22.7% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-03-03
Q1 2021 -$222M -$53M -$15M -39.4% Jan 1, 2021 Mar 31, 2021 10-K/A 2023-03-03
Q4 2020 -$207M -$59.6M -$29.6M -98.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$177M -$58.8M -$34.6M -143% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 -$142M -$50.3M -$27.6M -122% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 -$115M -$38M -$19.9M -110% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 -$95M -$30M -$15.5M -107% Oct 2, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$79.5M -$24.2M -$12.9M -113% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$66.6M -$22.7M -$14.9M -190% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$51.7M -$18.1M -$11.1M -156% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$40.7M -$14.5M -$5.54M -62.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$35.1M -$11.3M -$2.7M -31.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$32.4M -$7.83M +$613K +7.26% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$33.1M -$7.07M -$994K -16.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$32.1M -$8.91M -$1.16M -14.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$30.9M -$8.64M +$5.45M +38.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$36.4M -$8.44M -$5.8M -220% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$30.6M -$6.08M -$5.34M -723% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$25.2M -$7.76M +$2.63M +25.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$27.8M -$14.1M -$13.2M -1501% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$14.6M -$2.64M +$16.9M +86.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$31.5M -$738K +$19.6M +96.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$51.1M -$10.4M +$9.51M +47.8% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-15
Q3 2015 -$60.6M -$880K +$18.6M +95.5% Jul 1, 2015 Sep 30, 2015 10-Q/A 2017-03-31
Q2 2015 -$79.2M -$19.5M +$2.2M +10.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-20
Q1 2015 -$81.4M -$20.3M +$2.58M +11.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$84M -$19.9M +$3.55M +15.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$87.5M -$19.4M +$2.35M +10.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$89.8M -$21.7M +$362K +1.64% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$90.2M -$22.9M -$2.65M -13.1% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$87.6M -$23.4M -$5.74M -32.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$81.8M -$21.8M -$7.26M -49.9% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$74.6M -$22.1M -$7.93M -56.1% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$66.6M -$20.3M -$5.69M -39.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 -$60.9M -$17.7M -$7.46M -72.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-11
Q3 2012 -$53.5M -$14.5M -$2.32M -19% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-11
Q2 2012 -$51.2M -$14.1M -$2.13M -17.7% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-11
Q1 2012 -$49M -$14.6M -$3.6M -32.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-11
Q4 2011 -$45.4M -$10.2M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$12.2M -$1.99M -19.4% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-14
Q2 2011 -$12M -$2.97M -32.8% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-14
Q1 2011 -$11M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-14
Q3 2010 -$10.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 -$9.04M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.